Profile of Helicobacter pylori cytotoxin derived from two areas of Japan with different prevalence of atrophic gastritis

Gut

Volumn 39, Issue 6, 1996, Pages 800-806

  Ito, S ^a   Azuma, T ^a   Murakita, H ^a   Hirai, M ^a   Miyaji, H ^a   Ito, Y ^a   Ohtaki, Y ^a   Yamazaki, Y ^a   Kuriyama, M ^a   Keida, Y ^b   Kohli, Y ^c  

^a UNIVERSITY OF FUKUI   (Japan)

^b Okinawa Prefectural Chubu Hospital   (Japan)

^c Aiseikai Yamashina Hospital   (Japan)

Author keywords

gastric atrophy; Helicobacter pylori; vacuolating cytotoxin

Indexed keywords

CYTOTOXIN;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; ENDOSCOPY; GASTRITIS; GASTRODUODENAL ULCER; HELICOBACTER PYLORI; HUMAN; JAPAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; STOMACH CANCER;

EID: 8044223422     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.39.6.800     Document Type: Article

References (54)

1. Watanabe S, Arimoto H. Long term trends in cancer mortality rates and cumulative rates from 1955 to 1987 in Japan (II). Jpn J Clin Oncol 1989; 19: 413-25.
2. Statistics and Information Department, Minister's Secretariat. Vital Statistics of Japan. Tokyo: Ministry of Health and Welfare, 1992 (in Japanese).
3. Tsugane S, Kabuto M, Imai H, Gey F, Tei Y, Hanaoka T, et al. Helicobacter pylori, dietary factors and atrophic gastritis in five Japanese populations with different gastric cancer mortality. Cancer Causes Control 1993; 4: 297-305.
4. Kabuto M, Imai H, Tsugane S, Watanabe S. Correlation between atrophic gastritis prevalence and gastric cancer mortality among middle-aged men in 5 areas in Japan. J Epidemiol 1993; 3: 35-9.
5. Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 1986; 8: 1-27.
6. Blaser MJ. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. JInfect Dis 1990; 161: 626-33.
7. Craanen ME, Dekker W, Blok P, Ferwerda J, Tytgat GNJ. Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut 1992; 33: 16-20.
8. Sakaki N, Momma K, Yamada Y, Tadokoro Y, Tajima T. Helicobacter pylori infection and the development of atrophic gastritis assessed by endoscopy. Eur J Gastroenterol Hepatol 1992; 4: 585-7.
9. Kohli Y, Kato T, Iwaki M, Ito S, Suzuki K. Endoscopic diagnosis of Helicobacter pylori distribution in gastric mucosa of patients with chronic gastritis. Eur J Gastroenterol Hepatol 1993; 5 (suppl 1): S127-31.
10. Blaser MJ, Kobayashi K, Cover TL, Cao TL, Feurer ID, Perez-Perez GI. Helicobacter pylori infection in Japanese patients with adenocarcinoma of the stomach. Int J Cancer 1993; 55: 799-802.
11. Nomura A, Stemmerman GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma in a population of Japanese-Americans in Hawaii. N Engl J Med 1991; 325: 1132-6.
12. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
13. The Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 1359-62.
14. Akopyanz N, Bukanov NO, Westblom TU, Kresovich S, Berg DE. DNA diversity among clinical isolates of Helicobacter-pylori detected by PCR-based RAPD fingerprinting. Nucleic Acids Res 1992; 20: 5137-12.
15. Prewett EJ, Bickley J, Owen RJ, Pounder RE. DNA patterns of Helicobacter pylori isolated from gastric antrum, body, and duodenum. Gastroenterology 1992; 102: 829-33.
16. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chou PH, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111-5.
17. Hirai M, Azuma T, Ito S, Kato T, Kohli Y, Fujiki N. High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric-carcinoma patients. Int J Cancer 1994; 56: 56-60.
18. Price AB. The Sydney System: histological division. J Gastroenterol Hepatol 1991; 6: 209-22.
19. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969; 3: 87-97.
20. Kimura K. Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 1972; 63: 584-92.
21. Kimura K, Satoh K, Ido K, Taniguchi Y, Takimoto T, Takemoto T. Gastritis in the Japanese stomach. Scand J Gastroenterol 1996; 31 (suppl 214): S17-20.
22. Kohli Y, Pfeiffer CJ, Kutty KP, Barrowman JA, Heughan C, Kepkay DL. Endoscopic diagnosis of intestinal metaplasia in Canada and Japan. J Clin Gastroenterol 1981; 3 (suppl 1): S29-33.
23. Correa P. Chronic gastritis: A clinico-pathological classification. Am J Gastroenterol 1998; 83: 504-9.
24. Murakita H, Hirai M, Ito S, Azuma T, Kato T, Kohli Y. Vacuolating cytotoxin production by Helicobacter pylori isolates from peptic ulcer, atrophic gastritis and gastric carcinoma patients. Eur J Gastroenterol Hepatol 1994; 6 (suppl 1): S29-31.
25. Fox JG, Correa P, Taylor NS, Thompson N, Fontham E, Janney F, et al. High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis. Am J Gastroenterol 1992; 87: 1554-9.
26. Cover TL, Cao P, Lind CD, Tham KT, Blaser MJ. Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect Immun 1993; 61: 5008-12.
27. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci 1993; 90: 5791-5.
28. Kohli Y, Kato T, Suzuki K, Tada T, Fujiki N. Incidence of atrophic gastritis with age in Japan and Canada. Jpn J Med 1987; 26: 158-61.
29. Hosokawa O. Clinical study of 2157 cases with early gastric cancer in the Division of Surgery, Fukui Prefectural Hospital. Fukui, Yoshidakinbundo, 1996 (in Japanese).
30. Sipponen P, Kekki M, Haapakoski J, Ihamaki T, Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985; 35: 173-7.
31. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award lecture on cancer epidemiology and prevention. Cancer Res 1992; 52: 6735-40.
32. Tummuru MKR, Cover TL, Blaser MJ. Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori. Infect Immun 1994; 62: 2609-13.
33. Xiang Z, Censini S, Bayeli PF, Telford JL, Figura N, Rappuoli R, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995; 63: 94-8.
34. Tonokatsu Y, Hayashi T, Fukuda Y, Tamura T, Shimoyama T. A clinico-epidemiological analysis of Helicobacter pylori (H pylori) by southern blotting with a urease gene proble. J Gastroenterol 1994; 29: 120-4.
35. Megraud F, Cantet F, Hua J, Birac C, Cayla R, Lamouliatte H. Molecular fingerprinting of Helicobacter pylon strains shows a low intrapatient heterogeneity. Gastroenterology 1994; 106 (suppl): A136.
36. Taylor NS, Fox JG, Akopyants NS, Berg DE, Thompson N, Shames B, et al. Long-term colonization with single and multiple strains of Helicobacter pylon assessed by DNA fingerprinting. J Clin Microbiol 1995; 33: 918-23.
37. Cover TL, Tummuru MKR, Cao P, Thompson SA, Blaser MJ. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem 1994; 269: 10566-73.
38. Phadnis SH, Ilver D, Janzon L, Normark S, Westblom TU. Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori. Infect Immun 1994; 62: 1557-65.
39. Atherton JC, Cao P, Peek RM, Tummuru MKR, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. J Biol Chem 1995; 30: 17771-7.
40. Schmitt W, Haas R. Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported protein. Mol Microbiol 1994; 12: 307-19.
41. Blaser MJ, Chyou PH, Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res 1995; 55: 562-5.
42. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, et al. Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet 1992; 339: 896-7.
43. Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992; 102: 760-6.
44. Graham DY, Malaty HM, Evans DG, Evans DJ, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Gastroenterology 1991; 100: 1495-501.
45. Forman D, Webb P, Parsonnet J. Helicobacter pylori and gastric cancer. Lancet 1994; 343: 243-4.
46. Fukuda H, Saito D, Hayashi S, Hisai H, Ono H, Yoshida S, et al. Helicobacter pylori infection, serum pepsinogen level and gastric cancer: A case-control study in Japan. Jpn J Cancer Res 1995; 86: 64-71.
47. Ching CK, Lam SK. Helicobacter pylori epidemiology in relation to peptic ulcer and gastric cancer in South and North China. J Gastroenterol Hepalol 1994; 9: S4-7.
48. Sierra R, Muñoz N, Pèna AS, Biemond I, Duijn W, Lamers CBHW, et al. Antibodies to Helicobacter pylori and pepsinogen levels in children from Costa Rica: comparison of two areas with different risks for stomach cancer. Cancer Epidemiol Biomarkers Prev 1992; 1: 449-54.
49. Palli D, Decarli A, Cipriani F, Sitas F, Forman D, Amdori D, et al. Helicobacter pylori antibodies in areas of Italy at varying gastric cancer risk. Cancer Epidemiol Biomarkers Prev 1993; 2: 37-40.
50. Crabtree JE, Taylor JD, Wyatt JI, Heatly RV, Shallcross TM, Tompkins DS, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 1991; 338: 332-5.
51. Schlemper RJ, Werf SDJ, Vandenbroucke JP, Biemond I, Lamers CBHW. Seroepidemiology of gastritis in Japanese and Dutch working populations: evidence for the development of atrophic gastritis that is not related to Helicobacter pylori. Gut 1995; 37: 199-204.
52. Azuma T, Konishi J, Tanaka Y, Hirai M, Ito S, Kato T, et al. Contribution of HLA-DQA gene to host's response against Helicobacter pylori. Lancet 1994; 343: 542-3.
53. Beales ILP, Davey NJ, Pusey CD, Lechler RI, Calam J. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995; 346: 381-2.
54. Boren T, Falk P, Roth KA, Larson G, Normark S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993; 262: 1892-5.